Gabapentin enacarbil

DRUG6 trials

Sponsors

XenoPort, Inc., Astellas Pharma Inc, National Institute on Alcohol Abuse and Alcoholism (NIAAA), The Cleveland Clinic, University of Texas at Austin

Conditions

Alcohol Use DisorderAlzheimer DiseasePainRestless Legs Syndrome (RLS)

Phase 1

Study to Assess the Effect of Gabapentin Enacarbil on Simulated Driving in Healthy Subjects

CompletedNCT01411124

XenoPort, Inc.Restless Legs Syndrome (RLS)

Start: 2011-06-30End: 2011-10-31Updated: 2013-07-16

Phase 2

HORIZANT (Gabapentin Enacarbil Extended-Release Tablets) for the Treatment of Alcohol Use Disorder

CompletedNCT02252536

National Institute on Alcohol Abuse and Alcoholism (NIAAA)Alcohol Use Disorder

Start: 2015-06-30End: 2017-03-31Updated: 2018-11-14

Phase 4

Post-marketing Study of Gabapentin Enacarbil to Evaluate the Effect in Restless Leg Syndrome (RLS) Patients With Moderate Renal Impairment

CompletedNCT01981941

Astellas Pharma IncRestless Legs Syndrome (RLS)

Start: 2013-11-05End: 2015-05-13Updated: 2024-11-08

A Study of Oral Dosing of Gabapentin Enacarbil in Japanese Restless Legs Syndrome Patients

CompletedNCT03053427

Astellas Pharma IncRestless Legs Syndrome (RLS)

Start: 2017-03-30End: 2018-06-25Updated: 2024-12-12

Nighttime Agitation and Restless Legs Syndrome in People With Alzheimer's Disease

RecruitingNCT03082755

University of Texas at AustinAlzheimer Disease

Start: 2017-07-01End: 2023-03-31Target: 156Updated: 2022-05-18

Unknown Phase

Effect of Gabapentin Enacarbil on Opioid Consumption and Pain Scores

CompletedNCT02840240

The Cleveland ClinicPain

Start: 2016-01-31End: 2021-04-23Updated: 2024-01-09

Related Papers

Nighttime Agitation and Restless Legs Syndrome in Persons With Alzheimer's Disease: Study Protocol for a Double-Blind, Placebo-Controlled, Randomized Trial (NightRest)

Research in Gerontological Nursing2020-09-237 citations